版本:
中国

BRIEF-Newron Pharmaceuticals receives 11.3 million euros milestone payments for US approval of Xadago

May 12 NEWRON PHARMACEUTICALS SPA:

* RECEIVES EUR11.3M MILESTONE PAYMENTS FOR U.S. APPROVAL OF XADAGO (SAFINAMIDE) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐